Explore more publications!

Health & Wellness Today New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.

Press releases published on October 23, 2025

Iovance Biotherapeutics to Host Third Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, November 6, 2025
BBOT Presents Preclinical Data Demonstrating Potential of BBO-11818 as a Potent panKRAS Inhibitor at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Rani Therapeutics Announces the Appointments of Abe Bassan and Vasudev Bailey, Ph.D. to Board of Directors
SciSparc Announces Closing of the Sale to N2OFF of Majority-Owned Subsidiary MitoCareX, Advancing Drug Discovery for Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer
Anika to Issue Third Quarter 2025 Financial Results on Wednesday, November 5, 2025
Galapagos to Present In Vitro Data at ACR Convergence 2025 Suggesting Differentiation of GLPG3667 from Other TYK2 Inhibitors
Kiniksa Pharmaceuticals to Report Third Quarter 2025 Financial Results on October 28, 2025
Galapagos presenteert in vitro-gegevens tijdens ACR Convergence 2025 die wijzen op differentiatie van GLPG3667 ten opzichte van andere TYK2-remmers
Carlsmed Inc. to Report Third Quarter 2025 Financial Results on November 6, 2025
Rani Therapeutics Announces Closing of Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules
Leukemia Survivor Introduced to Lifesaving Donor by Former NFL Player at Boston College Donor Drive
Carrington College in Albuquerque Invites Community to Explore Healthcare Careers at Nursing Open House
New Clinical Data Confirms Yomi® Robotic System Enhances Efficiency in Dental Implant Surgery
Award-Winning Film An Inconvenient Study Sparks Global Debate on Vaccine Safety and Chronic Disease
Progyny, Inc. Announces Details for Its Third Quarter 2025 Results Report
Europe Approves New Alzheimer’s Treatment -- Why is the U.S. Still Waiting?
Hidradenitis Suppurativa Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 24+ Companies and 26+ Therapies | DelveInsight
Zymeworks Presents Initial Clinical Data from the Phase 1 trial of ZW191, an Antibody-Drug Conjugate Targeting Folate Receptor-⍺ at AACR-NCI-EORTC Conference
ALX Oncology Announces Preclinical Data and Phase 1 Trial-in-Progress Presentations of ALX2004, a Novel EGFR-Targeted ADC, at 2025 AACR-NCI-EORTC Conference
eteraflex connects and CliniExperts Announce Global Alliance to Redefine Clinical Research and Regulatory Services Delivery

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions